Kalaris Therapeutics, Inc. Common Stock (KLRS)

• Market cap: $148M
• 1 day: -1.62%
• 5 days: -12.61%
• 1 month: -21.16%
• 3 months: -23.67%
• 6 months: -57.84%
• Year to date: -23.67%
• 1 year: -57.32%
• 5 years: -98.65%
• 10 years: -98.65%
• Sector: Healthcare
• Industry: Biological Products, Except Diagnostic Substances

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

12% less funds holding

Funds holding: 60 [Q3] → 53 (-7) [Q4]

31% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 16

32% less capital invested

Capital invested by funds: $36.3M [Q3] → $24.6M (-$11.7M) [Q4]

35% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 17